סך נכסי הפעילות העסקית Acumen Pharmaceuticals Inc. (ABOS)
Acumen Pharmaceuticals (ABOS) is creating a closed ecosystem to combat Alzheimer's disease using proprietary antibodies against amyloid oligomers. The price history on this chart confirms asset dynamics, which currently stand at 113.89. Business potential is fueled by data on the ACU193 drug and the global aging population. Technological superiority is ensured by patents for safe molecules, creating a significant barrier for competitors in the biotech sector.
פילוחים אנליטיים של חברת Acumen Pharma (ABOS)
Total assets represent the sum of all resources and liabilities of the issuer, calculated reverse-engineered via return on assets (ROA) to identify hidden base distortions. By analyzing changes in the company's financial assets, an investor can assess the capitalization stability of Acumen Pharmaceuticals (ABOS), whose value relies on exclusive patents in Alzheimer's disease therapy and the potential for market dominance.